Related references
Note: Only part of the references are listed.Survival differences in nasopharyngeal carcinoma among racial and ethnic minority groups in the United States: A retrospective cohort study
Sai D. Challapalli et al.
CLINICAL OTOLARYNGOLOGY (2019)
Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma
Nicholas C. J. Lee et al.
CANCER (2019)
Facility Volume and Survival in Nasopharyngeal Carcinoma
Emi J. Yoshida et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B. Y. Ma et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Prognostic Model for Stratification of Radioresistant Nasopharynx Carcinoma to Curative Salvage Radiotherapy
You Quan Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
Anthony T. C. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Anne W. Lee et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines
Vincent Gregoire et al.
RADIOTHERAPY AND ONCOLOGY (2018)
A National Study of Survival Trends and Conditional Survival in Nasopharyngeal Carcinoma: Analysis of the National Population-Based Surveillance Epidemiology and End Results Registry
Jia-Wei Lv et al.
CANCER RESEARCH AND TREATMENT (2018)
Patterns of Failure and Survival Trends Of 720 Patients with Stage I Nasopharyngeal Carcinoma Diagnosed from 1990-2012: A Large-scale Retrospective Cohort Study
Lin-Quan Tang et al.
JOURNAL OF CANCER (2018)
Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
Fangfang Kong et al.
BMC CANCER (2018)
SEOM clinical guideline in nasopharynx cancer (2017)
M. Pastor et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
The efficacy of first-line chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis
Shu-Xiang Ma et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
A preliminary report on the role of endoscopic endonasal nasopharyngectomy in recurrent rT3 and rT4 nasopharyngeal carcinoma
Eugene Hung Chih Wong et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2017)
Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma
Oscar S. H. Chan et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Racial and Ethnic Disparities in Nasopharyngeal Cancer Survival in the United States: A SEER Study
Vishal J. Patel et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2017)
Evolving trends in head and neck cancer epidemiology: Ontario, Canada 1993-2010
Matthew Mifsud et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Risk of nasopharyngeal carcinoma penetrates across immigrant generations: A migrant cohort study of 2.3 million Jewish Israeli adolescents
Yakir Rottenberg et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience
Juan Liu et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
Chiun Hsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Critical Evaluation of the Quality and Recommendations of Clinical Practice Guidelines for Nasopharyngeal Carcinoma
Yu-Pei Chen et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer
K. C. Allen Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
CT-guided 125I brachytherapy for locally recurrent nasopharyngeal carcinoma
Huzheng Yan et al.
JOURNAL OF CANCER (2017)
Clinical outcomes of residual or recurrent nasopharyngeal carcinoma treated with endoscopic nasopharyngectomy plus chemoradiotherapy or with chemoradiotherapy alone: a retrospective study
Jingjin Weng et al.
PEERJ (2017)
Epidemiology and outcomes of nasopharyngeal carcinoma: Experience from a regional cancer center in Southern India
Rudresha Antapura Haleshappa et al.
SOUTH ASIAN JOURNAL OF CANCER (2017)
Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA
Ji-Jin Yao et al.
CANCER SCIENCE (2017)
Palliative systemic therapy for recurrent or metastatic nasopharyngeal carcinoma - How far have we achieved?
Victor Lee et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx
Edward B. Stelow et al.
HEAD & NECK PATHOLOGY (2017)
Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma
Yun-Ming Tian et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Long-term outcomes of nasopharyngectomy using partial maxillectomy approach
Li Shia Ng et al.
LARYNGOSCOPE (2016)
Asian Versus Non-Asian Outcomes in Nasopharyngeal Carcinoma: A North American Population-based Analysis
Sarah N. Hamilton et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Global trends in incidence and mortality of nasopharyngeal carcinoma
Ling-Ling Tang et al.
CANCER LETTERS (2016)
Outcomes in nasopharyngeal carcinoma: Results from a nonendemic cohort
S. G. Laskar et al.
INDIAN JOURNAL OF CANCER (2016)
Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines
R. Simo et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2016)
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Li Zhang et al.
LANCET (2016)
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Ying Sun et al.
LANCET ONCOLOGY (2016)
Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinoma
Dan Ou et al.
ORAL ONCOLOGY (2016)
Nasopharyngeal carcinoma in a low incidence European area A prospective observational analysis from the Head and Neck Study Group of the Italian Society of Radiation Oncology (AIRO)
S. Tonoli et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2016)
Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma
Lin Kong et al.
JOURNAL OF CANCER (2016)
Outcomes in nasopharyngeal carcinoma: Results from a nonendemic cohort
S. G. Laskar et al.
INDIAN JOURNAL OF CANCER (2016)
A new prognostic histopathologic classification of nasopharyngeal carcinoma
Hai-Yun Wang et al.
CHINESE JOURNAL OF CANCER (2016)
Institutional Clinical Trial Accrual Volume and Survival of Patients With Head and Neck Cancer
Evan J. Wuthrick et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
Pierre Blanchard et al.
LANCET ONCOLOGY (2015)
Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma - A case-matched comparison
Rui You et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Current Cigarette Smoking Among Adults — United States, 2005–2014
Ahmed Jamal et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Reirradiation with Robotic Stereotactic Body Radiotherapy for Recurrent Nasopharyngeal Carcinoma
Aysen Dizman et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Nonendemic HPV-Positive Nasopharyngeal Carcinoma: Association With Poor Prognosis
Matthew H. Stenmark et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT
Wai Tong Ng et al.
ORAL ONCOLOGY (2014)
Quantitative Association of Tobacco Smoking With the Risk of Nasopharyngeal Carcinoma: A Comprehensive Meta-Analysis of Studies Conducted Between 1979 and 2011
Wen-Qiong Xue et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China
Yong Chen et al.
CANCER (2013)
Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy
Cui Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Racial differences in nasopharyngeal carcinoma in the United States
Yu Wang et al.
CANCER EPIDEMIOLOGY (2013)
Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines
A. D'cruz et al.
ORAL ONCOLOGY (2013)
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
Lei Chen et al.
LANCET ONCOLOGY (2012)
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma
Gang Peng et al.
RADIOTHERAPY AND ONCOLOGY (2012)
The prevalence and prevention of nasopharyngeal carcinoma in China
Su-Mei Cao et al.
Chinese Journal of Cancer (2011)
Nasopharyngeal and hypopharyngeal carcinoma risk among immigrants in Sweden
Seyed Mohsen Mousavi et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
HLA Associations with Nasopharyngeal Carcinoma
Xin Li et al.
CURRENT MOLECULAR MEDICINE (2009)
Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review
W. M. Yu et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2009)
Prospective Randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients
Michael K. M. Kam et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997
Juhua Luo et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2007)
Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial
Edmond H. N. Pow et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
The enigmatic epidemiology of nasopharyngeal carcinoma
Ellen T. Chang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety
J Wee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Survival outcome of patients with nasopharyngeal carcinoma with first local failure: A study by the Hong Kong Nasopharyngeal Carcinoma Study Group
KH Yu et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2005)
Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma
JY Shao et al.
CANCER (2004)
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma
JC Lin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Detection of Epstein-Barr virus in metastatic lymph nodes of patients with nasopharyngeal carcinoma and a primary unknown carcinoma
K Nakao et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2003)
Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): An encouraging reduction in both incidence and mortality
AWM Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma
CY Hsiung et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial
ATC Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
